CANCER INSIGHT
LIVE

Serial Number

97053419

Owner

Cancer Insight, LLC

Attorney

Megan R. Bradshaw

Filing Date

Sep 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CANCER INSIGHT Trademark

Serial Number: 97053419 • Registration: 6933774

CANCER INSIGHT is a trademark filed by Cancer Insight, LLC on September 30, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Cancer Insight, LLC

1305 East Houston Street
San Antonio, TX 78205

Entity Type: 16

CANCER INSIGHT, LLC D/B/A LUMABRIDGE

1305 E. HOUSTON ST.
SAN ANTONIO, TX 78205

Entity Type: 16

Trademark Details

Filing Date

September 30, 2021

Registration Date

December 27, 2022

Published for Opposition

October 11, 2022

Goods & Services

Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing business intelligence services in the fields of medical devices and pharmaceuticals

Regulatory compliance consulting in the field of medical products; Regulatory compliance consulting in the field of prescription drug sampling

Medical and scientific research, namely, conducting clinical trials for others; Conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Medical research; Scientific research and development; Biomedical research services; Providing information about medical and scientific research; Research and development of vaccines and medicines; Consulting services in the fields of biotechnology and pharmaceutical research and development; Pharmaceutical research and development; Pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 8, 2023 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 27, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 11, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 11, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 21, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 4, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 30, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 30, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 30, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 30, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2021 NWOS
NEW APPLICATION ENTERED
Oct 4, 2021 NWAP